ReviewImmunology and allergy clinics of North America2010
Quality-of-life outcomes and measurement in childhood atopic dermatitis.
Review in Immunology and allergy clinics of North America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- The Health Benefits of Probiotic Lactiplantibacillus plantarum: A Systematic Review and Meta-Analysis.Probiotics and antimicrobial proteins · 2025Pooled it
- The Use of Decision-Analytic Models in Atopic Eczema: A Systematic Review and Critical Appraisal.PharmacoEconomics · 2018Pooled it
- Probiotics for the Treatment of Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Frontiers in cellular and infection microbiology · 2017Pooled it
- Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.Advances in therapy · 2024Trial
- Improved patient- and caregiver-reported outcomes distinguish tacrolimus 0.03% from crisaborole in children with atopic dermatitis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2024Trial
- Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis.Advances in therapy · 2024Trial
- Associations of Atopic Dermatitis in Late Adolescence with Occupation, Mental Health, Income from Work and Marital Status: A National Longitudinal Study.Acta dermato-venereologica · 2025Article
- Effects of dual therapy with betamethasone and tetracycline in a NC/Nga mouse model of atopic dermatitis.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2023Article
- Expanding Personalized, Data-Driven Dermatology: Leveraging Digital Health Technology and Machine Learning to Improve Patient Outcomes.JID innovations : skin science from molecules to population health · 2022Review
- Either transepidermal water loss rates or stratum corneum hydration levels can predict quality of life in children with atopic dermatitis.Pediatric investigation · 2021Article
- Epidemiologic features and burden of atopic dermatitis in adolescent and adult patients: A cross-sectional multicenter study.The World Allergy Organization journal · 2021Article
- The Moyamoya Health Behavior Scale for Adolescent Patients: Measurement Tool Development and Psychometric Evaluation.International journal of environmental research and public health · 2021Article
- The Challenge of Managing Atopic Dermatitis in the United States.American health & drug benefits · 2019Review
- Article
- Mental health associations with eczema, asthma and hay fever in children: a cross-sectional survey.BMJ open · 2016Article
- Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2015Review
- Parents' experience of childhood atopic eczema in the public health sector of Gauteng.Curationis · 2015Article
- Comparing the impact of psoriasis and atopic dermatitis on quality of life: co-calibration of the PSORIQoL and QoLIAD.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2015Article
- Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.The Journal of allergy and clinical immunology · 2014Article
- Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids.The Journal of clinical and aesthetic dermatology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Atopic dermatitis is a common childhood skin disease of increasing prevalence that greatly affects the quality-of-life of affected children and their families. The complex and multidimensional effects of this disease have been described qualitatively and measured quantitatively with quality-of-life instruments. The burden of atopic dermatitis can likely be improved by identifying parents and their caregivers with impaired quality-of-life and providing appropriate education and psychosocial support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.